SCHEMBL1770081

SCHEMBL1770081

CCN(C(=O)OC(C)(C)C)c1ccc(C(=O)C2=C(O)c3sc(NC(C)=O)nc3CCC2)cn1.FB(F)F

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
CFTR P13569 3/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
OGA O60502 1/20 0.30
CCNB2 O95067 1/20 0.30
CCNE2 O96020 1/20 0.30
CDK1 P06493 1/20 0.30
CDK4 P11802 1/20 0.30
CCNB1 P14635 1/20 0.30
CCND1 P24385 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30
CCNB3 Q8WWL7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1770958 0.90 ABL1 (0.34) PI4KAPI4KBCFTRNPC1ALDH1A1
SCHEMBL691699 0.86 CFTR (0.34) CFTRNPC1ALDH1A1POLBRAB9A
SCHEMBL692451 0.86 NPC1 (0.37) CFTRNPC1ALDH1A1TP53POLB
SCHEMBL2671947 0.83 PI4KB (0.36) PI4KAPI4KBALDH1A1GPR119OGA
SCHEMBL12649327 0.80 GPR119 (0.35) PI4KAPI4KBNPC1ALDH1A1TP53
SCHEMBL691255 0.79 ALDH1A1 (0.39) PI4KBCFTRNPC1ALDH1A1TP53
SCHEMBL1781135 0.76 PIK3CG (0.39) NPC1ALDH1A1TP53POLBRAB9A
SCHEMBL27869088 0.75 CFTR (0.32) PI4KAPI4KBCFTRNPC1ALDH1A1
SCHEMBL1781088 0.75 PI4KB (0.35) PI4KAPI4KBGPR119
SCHEMBL4949067 0.75 LMNA (0.37) PI4KAPI4KBNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110112087-A1 Thia-triaza-cyclopentazulenes BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112087-A1 Thia-triaza-cyclopentazulenes CCNA1, MKI67, CCNT1 PI4KA 4602/4885PI4KB 4844/4885CFTR 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.